Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ankit Mahadevia Insider Profile
4 Followers
Ankit Mahadevia, Director at Spero Therapeutics, holds 759.09K shares in Spero Therapeutics (Ticker: SPRO). Most recently, Ankit Mahadevia Sold $5,912 shares of Spero Therapeutics on Aug 29, 2024 for an estimated value of 7.98K.
Profitable Transactions
4 out of 4 Profitable Transactions
Average Return
+9.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ankit Mahadevia's holdings
Insider Roles
Director
Roles that Ankit Mahadevia holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Feb 06, 2023 - Feb 06, 2024
Return:+21.60%
The most profitable trade made by Ankit Mahadevia
Ankit Mahadevia's Trading History
List of latest transactions for each holding click on a transaction to see Ankit Mahadevia's performance on stock
You May Also Like
Ankit Mahadevia insider profile FAQ
What is the percentage of profitable transactions made by Ankit Mahadevia?
The percentage of profitable transactions made by Ankit Mahadevia is 100%.
What is the average return per transaction made by Ankit Mahadevia?
The average return per transaction made by Ankit Mahadevia is 9.50%.
What stocks does Ankit Mahadevia hold?
Ankit Mahadevia holds: SPRO stocks.
What was Ankit Mahadevia’s latest transaction?
Ankit Mahadevia latest transaction was an Informative Sell of $7.98K.
What was Ankit Mahadevia's most profitable transaction?
Ankit Mahadevia’s most profitable transaction was an Informative Sell of SPRO stock on February 6, 2023. The return on the trade was 21.60%.
What is Ankit Mahadevia's role in Spero Therapeutics?
Ankit Mahadevia's role in Spero Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.